查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1538448

醫藥級磷脂市場報告：2030 年趨勢、預測與競爭分析

Pharmaceutical Grade Phospholipid Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

醫藥級磷脂的趨勢與預測

2024年至2030年，全球醫藥級磷脂市場預計將以4.4%的複合年成長率成長。該市場的主要促進因素是對基於脂質的藥物傳輸系統的需求不斷成長、藥物製劑中磷脂的使用不斷增加以及對藥物生物有效性和藥物穩定性的日益關注。由於製藥和醫療市場的機遇，全球醫藥級磷脂市場的未來前景看好。

醫藥級磷脂依細分市場分類

該研究包括按類型、應用和地區分類的全球醫藥級磷脂的預測。

醫藥級磷脂市場洞察

Lucintel 預測天然磷脂會有更高的成長。

在這個市場中，藥品預計將呈現更高的成長。

亞太地區預計成長最快。

常問問題

Q1.市場成長預測是多少：

A1. 2024年至2030年，全球醫藥級磷脂市場預計將以4.4%的複合年成長率成長。

Q2. 影響市場成長的關鍵促進因素是：

A2. 該市場的主要促進因素是對基於脂質的藥物傳輸系統的需求不斷成長、藥物製劑中磷脂的使用不斷增加以及對藥物生物有效性和藥物穩定性的日益關注。

Q3.市場的主要細分市場是：

A3. 由於醫藥和醫療市場的機遇，醫藥級磷脂市場的未來性廣闊。

Q4.市場的主要企業是：

A4. 生產醫藥級磷脂質的主要企業如下：

  • Cargill Incorporated
  • Avril
  • Sime Darby Oils
  • Croda Pharma
  • Nippon Fine Chemical
  • Nof Corporation
  • Suzhou Fushilai Pharmaceutical
  • LIPOID
  • Louis Dreyfus Company
  • Shenyang Tianfeng Bio-Pharm

Q5.未來最大的細分市場是什麼？

A5.Lucintel 預測天然磷脂的成長速度較快。

Q6.未來五年預計哪些地區的市場成長最大？

A6.亞太地區預計成長最快。

Q7. 可以客製化報告嗎？

A7。

目錄

第1章執行摘要

第2章全球藥用級磷脂市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球藥用級磷脂市場趨勢（2018-2023）與預測（2024-2030）
  • 全球藥用級磷脂市場（按類型）
    • 天然磷脂
    • 合成磷脂
  • 全球藥用級磷脂市場（按應用）
    • 藥品
    • 醫療保健
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球藥用級磷脂市場（按地區）
  • 北美藥用級磷脂市場
  • 歐洲醫藥級磷脂市場
  • 亞太地區藥用級磷脂市場
  • 其他地區藥用級磷脂市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球藥用級磷脂市場的成長機會（按類型）
    • 全球藥用級磷脂市場成長機會（按應用）
    • 全球藥用級磷脂市場成長機會（按地區）
  • 全球藥用級磷脂市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球醫藥級磷脂市場產能擴張
    • 全球醫藥級磷脂市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Cargill Incorporated
  • Avril
  • Sime Darby Oils
  • Croda Pharma
  • Nippon Fine Chemical
  • Nof Corporation
  • Suzhou Fushilai Pharmaceutical
  • LIPOID
  • Louis Dreyfus Company
  • Shenyang Tianfeng Bio-Pharm
簡介目錄

Pharmaceutical Grade Phospholipid Trends and Forecast

The future of the global pharmaceutical grade phospholipid market looks promising with opportunities in the pharmaceutical and healthcare markets. The global pharmaceutical grade phospholipid market is expected to grow with a CAGR of 4.4% from 2024 to 2030. The major drivers for this market are rising demand for lipid-based drug delivery systems, increasing adoption of phospholipids in pharmaceutical formulations, and growing focus on bioavailability & drug stability in pharmaceutical products.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Pharmaceutical Grade Phospholipid by Segment

The study includes a forecast for the global pharmaceutical grade phospholipid by type, application, and region.

Pharmaceutical Grade Phospholipid Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Natural Phospholipids
  • Synthetic Phospholipids

Pharmaceutical Grade Phospholipid Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceuticals
  • Healthcare
  • Others

Pharmaceutical Grade Phospholipid Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Pharmaceutical Grade Phospholipid Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pharmaceutical grade phospholipid companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pharmaceutical grade phospholipid companies profiled in this report include-

  • Cargill Incorporated
  • Avril
  • Sime Darby Oils
  • Croda Pharma
  • Nippon Fine Chemical
  • Nof Corporation
  • Suzhou Fushilai Pharmaceutical
  • LIPOID
  • Louis Dreyfus Company
  • Shenyang Tianfeng Bio-Pharm

Pharmaceutical Grade Phospholipid Market Insights

Lucintel forecasts that natural phospholipid is expected to witness higher growth.

Within this market, pharmaceutical is expected to witness higher growth.

APAC is expected to witness the highest growth.

Features of the Global Pharmaceutical Grade Phospholipid Market

Market Size Estimates: Pharmaceutical grade phospholipid market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pharmaceutical grade phospholipid market size by type, application, and region in terms of value ($B).

Regional Analysis: Pharmaceutical grade phospholipid market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the pharmaceutical grade phospholipid market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pharmaceutical grade phospholipid market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for pharmaceutical grade phospholipid market?

Answer: The global pharmaceutical grade phospholipid market is expected to grow with a CAGR of 4.4% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the pharmaceutical grade phospholipid market?

Answer: The major drivers for this market are rising demand for lipid-based drug delivery systems, increasing adoption of phospholipids in pharmaceutical formulations, and growing focus on bioavailability & drug stability in pharmaceutical products.

Q3. What are the major segments for pharmaceutical grade phospholipid market?

Answer: The future of the pharmaceutical grade phospholipid market looks promising with opportunities in the pharmaceutical and healthcare markets.

Q4. Who are the key pharmaceutical grade phospholipid market companies?

Answer: Some of the key pharmaceutical grade phospholipid companies are as follows:

  • Cargill Incorporated
  • Avril
  • Sime Darby Oils
  • Croda Pharma
  • Nippon Fine Chemical
  • Nof Corporation
  • Suzhou Fushilai Pharmaceutical
  • LIPOID
  • Louis Dreyfus Company
  • Shenyang Tianfeng Bio-Pharm

Q5. Which pharmaceutical grade phospholipid market segment will be the largest in future?

Answer: Lucintel forecasts that natural phospholipid is expected to witness higher growth.

Q6. In pharmaceutical grade phospholipid market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness the highest growth.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the pharmaceutical grade phospholipid market by type (natural phospholipids and synthetic phospholipids), application (pharmaceuticals, healthcare, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pharmaceutical Grade Phospholipid Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Pharmaceutical Grade Phospholipid Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Pharmaceutical Grade Phospholipid Market by Type
    • 3.3.1: Natural Phospholipids
    • 3.3.2: Synthetic Phospholipids
  • 3.4: Global Pharmaceutical Grade Phospholipid Market by Application
    • 3.4.1: Pharmaceuticals
    • 3.4.2: Healthcare
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Pharmaceutical Grade Phospholipid Market by Region
  • 4.2: North American Pharmaceutical Grade Phospholipid Market
    • 4.2.1: North American Pharmaceutical Grade Phospholipid Market by Type: Natural Phospholipids and Synthetic Phospholipids
    • 4.2.2: North American Pharmaceutical Grade Phospholipid Market by Application: Pharmaceuticals, Healthcare, and Others
  • 4.3: European Pharmaceutical Grade Phospholipid Market
    • 4.3.1: European Pharmaceutical Grade Phospholipid Market by Type: Natural Phospholipids and Synthetic Phospholipids
    • 4.3.2: European Pharmaceutical Grade Phospholipid Market by Application: Pharmaceuticals, Healthcare, and Others
  • 4.4: APAC Pharmaceutical Grade Phospholipid Market
    • 4.4.1: APAC Pharmaceutical Grade Phospholipid Market by Type: Natural Phospholipids and Synthetic Phospholipids
    • 4.4.2: APAC Pharmaceutical Grade Phospholipid Market by Application: Pharmaceuticals, Healthcare, and Others
  • 4.5: ROW Pharmaceutical Grade Phospholipid Market
    • 4.5.1: ROW Pharmaceutical Grade Phospholipid Market by Type: Natural Phospholipids and Synthetic Phospholipids
    • 4.5.2: ROW Pharmaceutical Grade Phospholipid Market by Application: Pharmaceuticals, Healthcare, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Pharmaceutical Grade Phospholipid Market by Type
    • 6.1.2: Growth Opportunities for the Global Pharmaceutical Grade Phospholipid Market by Application
    • 6.1.3: Growth Opportunities for the Global Pharmaceutical Grade Phospholipid Market by Region
  • 6.2: Emerging Trends in the Global Pharmaceutical Grade Phospholipid Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Pharmaceutical Grade Phospholipid Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pharmaceutical Grade Phospholipid Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Cargill Incorporated
  • 7.2: Avril
  • 7.3: Sime Darby Oils
  • 7.4: Croda Pharma
  • 7.5: Nippon Fine Chemical
  • 7.6: Nof Corporation
  • 7.7: Suzhou Fushilai Pharmaceutical
  • 7.8: LIPOID
  • 7.9: Louis Dreyfus Company
  • 7.10: Shenyang Tianfeng Bio-Pharm